1800 202 8726
Radiotracer production costs

Why Specialised Tracers — Cost More Than FDG

If your oncologist has recommended a PSMA, DOTATATE or FAPI scan, the cost difference from a standard PET-CT is real. It reflects how the tracer is made, not a premium charged on top of equivalent care.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Production is the main cost driver — Specialised tracers are made in small batches at a handful of facilities, not mass-produced like FDG.
  • Half-life forces same-day use — Ga-68 tracers decay fast enough that most of a batch cannot be saved or transported far — what is not used that day is discarded.
  • Not all uses are equally established — PSMA and DOTATATE have strong guideline support for their indications. FAPI use is still being studied.
  • Indicative cost at partner centres — Specialised tracers are available at CION partner imaging centres at around ₹23,999 — indicative as of 2026, subject to change.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get an indicative cost estimate

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

PSMA, DOTATATE and FAPI cost more than FDG because they are made in much smaller batches, often at a single specialist facility, and must be used within hours of production. The cost per patient is higher because fewer patients share each production run. The difference reflects logistics and physics, not an inflated margin.

A whole-body PET-CT at CION costs from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.

How does FDG compare to PSMA, DOTATATE and FAPI?

FeatureFDG (standard PET-CT)PSMA / DOTATATE / FAPI
What it detectsGlucose uptake — active in most cancer cellsSpecific receptors on prostate, neuroendocrine or fibroblast-activated cells
How it is producedLarge regional cyclotrons supplying many centresFewer specialist cyclotrons, or table-top generators for Ga-68 tracers
Tracer half-lifeAround 110 minutes68 minutes (Ga-68 tracers) to 110 minutes (F-18 PSMA)
Patients per production runMany — fixed costs spread widelyFew — each patient absorbs a larger share of the production cost
Same-day logistics pressureModerate — regional supply networks existHigh — tracer must be dispatched, in transit and injected within a narrow window
Availability in IndiaWidespread across many imaging centresSpecialised partner centres only
Guideline supportEstablished across most tumour typesPSMA and DOTATATE: established for their indications. FAPI: emerging, under active study.
Indicative cost at partner centresIncluded in standard scan packageAround ₹23,999 — indicative as of 2026, subject to change

Why does producing these tracers cost so much more than FDG?

The answer is batch size. FDG is made by cyclotrons that supply dozens or hundreds of patients each day across a wide region. The production cost — equipment, staff, radiation safety, quality testing — is divided across a large number of scans, keeping the per-patient figure low.

Specialised tracers serve a narrower group of patients. A production run covering a city may supply only a small number of patients that day. Each one absorbs a larger share of the fixed cost of the run.

Gallium-68 tracers — used for DOTATATE and some PSMA imaging — decay to half their activity in 68 minutes. That short half-life is what makes them safe and precise. It also means that tracer produced at 7am cannot be given at 3pm. What is not used that day is discarded. That waste is built into the price.

What will this actually cost you?

Costs depend on the regimen, the number of cycles and your scheme eligibility. Send your reports and we will give you an itemised, indicative estimate.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Know the cost before you commit

An itemised estimate, plus a check of which schemes you may qualify for.

Book Free Consultation Call 1800 202 8726

Does the extra cost mean the scan is actually worth it?

That depends on whether the result will change your treatment decision — and that is a clinical question, not a cost question.

For prostate cancer, NCCN and ESMO guidance supports PSMA PET-CT for staging and recurrence detection where the result will guide what happens next. For neuroendocrine tumours, ENET and ESMO support DOTATATE PET-CT for the same reason.

FAPI PET-CT is being actively studied across several tumour types. Its role in routine care is not yet established in most international guidelines. If your team has recommended it, ask what evidence applies to your specific cancer and how the result will affect your treatment plan.

When a specialised tracer is recommended, it is because FDG cannot reliably provide the same information for that indication. You are paying for a different view, not a more expensive version of the same one.

What do half-life and cyclotron actually mean?

Half-life
The time it takes for a radiotracer to lose half its radioactivity. A short half-life is what makes PET tracers safe — the radiation clears your body quickly — but it also means the tracer must be made, transported and injected within a narrow window.
Cyclotron
A particle accelerator that produces F-18, the radioactive atom used in FDG and F-18 PSMA. Running one requires specialist staff, thick radiation shielding and continuous quality checks. There are far fewer cyclotrons than imaging centres, which is why tracer supply is a logistical chain, not a tap you turn on.
Generator-produced tracer
Ga-68 tracers such as DOTATATE can be produced from a table-top generator rather than a full cyclotron. The generator still produces a limited quantity per run and has a finite lifespan — it does not make large-batch production possible.
Established use
A clinical use supported by published evidence and included in major guidelines from bodies such as NCCN, ESMO or ENET. PSMA PET-CT for prostate cancer and DOTATATE PET-CT for neuroendocrine tumours are established uses.
Emerging use
A use under active investigation in clinical trials but not yet part of routine guidelines for most patients. FAPI PET-CT currently falls into this category for most tumour types. The evidence is being studied seriously; it cannot yet be described as standard of care.

PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.

Explore 72 more Specialised Tracers and How PET-CT Compares topics

All Specialised Tracers and How PET-CT Compares →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Why does a DOTATATE scan cost so much more than a regular PET-CT?

DOTATATE is produced from a generator that makes a limited quantity per run, and the tracer decays quickly enough that anything not used that day must be discarded. What you pay covers your share of the equipment, radiation safety protocols, quality testing and the logistics of getting the tracer to you within its usable window — costs that cannot be spread across a large batch the way FDG can. The price reflects the physics of the tracer, not a margin charged on top of a cheaper alternative.

Is PSMA PET-CT available in Hyderabad and Andhra Pradesh?

Yes. PSMA PET-CT is available at CION partner imaging centres in Hyderabad and across Telangana and Andhra Pradesh. Because the tracer must reach you quickly after production, availability is tied to centres within a manageable distance of a production facility. Your CION team can tell you which partner centre is appropriate for your location and how much lead time is needed to schedule the scan.

Can health insurance cover a PSMA or DOTATATE scan?

Reimbursement depends on your insurer and your specific policy. Some corporate and government health schemes cover PSMA and DOTATATE PET-CT for specific indications. You will generally need a written clinical recommendation from your oncologist explaining why the scan is needed for your treatment decision. Your CION team can help you gather the documentation required to submit a claim.

Why can't more tracer be made at once to bring the cost down?

The limiting factor is physics, not scale of effort. Ga-68 tracers decay too quickly to stockpile. F-18 PSMA production requires a cyclotron, and running it longer produces more tracer — but the usable window constrains how many patients a single batch can serve. As more facilities open across India and patient numbers grow, costs should reduce gradually. But the half-life sets a floor that cannot be engineered away.

My oncologist has recommended FAPI PET-CT. Is that an established test?

FAPI PET-CT is under active investigation in clinical trials across several tumour types and the early evidence is being studied seriously by the oncology community. It is not yet part of routine guidelines from NCCN, ESMO or ENET for most cancers. That does not mean it is without value — but before you proceed, it is reasonable to ask your oncologist which specific evidence applies to your cancer and how the result will affect your treatment plan. That question deserves a clear answer.

Will the cost of PSMA and DOTATATE scans come down over time?

We do not yet know the timeline, but costs typically reduce as more production facilities open, more centres are equipped to administer the scans, and the supply chain matures. That process is underway in India. How quickly it translates to lower patient costs depends on how fast the infrastructure grows and how regulatory pathways develop. For now, the cost reflects a genuinely limited and logistically constrained production process.

Call now Book free consultation